Sharps Compliance Corp. (NASDAQ:SMED) – Analysts at Barrington Research issued their Q3 2019 earnings estimates for Sharps Compliance in a note issued to investors on Thursday, October 25th. Barrington Research analyst K. Steinke forecasts that the industrial products company will earn ($0.01) per share for the quarter. Barrington Research has a “Buy” rating and a $5.00 price target on the stock. Barrington Research also issued estimates for Sharps Compliance’s Q4 2019 earnings at $0.03 EPS and FY2020 earnings at $0.10 EPS.
Separately, Zacks Investment Research upgraded Sharps Compliance from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 3rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. Sharps Compliance has an average rating of “Hold” and an average price target of $4.50.
Sharps Compliance (NASDAQ:SMED) last announced its quarterly earnings data on Tuesday, August 14th. The industrial products company reported ($0.01) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.03 by ($0.04). Sharps Compliance had a negative return on equity of 2.66% and a negative net margin of 1.66%. The business had revenue of $9.91 million for the quarter, compared to analyst estimates of $11.24 million.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Ingalls & Snyder LLC boosted its position in Sharps Compliance by 492.9% during the third quarter. Ingalls & Snyder LLC now owns 351,268 shares of the industrial products company’s stock worth $1,212,000 after purchasing an additional 292,018 shares in the last quarter. Quantum Capital Management boosted its position in Sharps Compliance by 78.4% during the second quarter. Quantum Capital Management now owns 265,105 shares of the industrial products company’s stock worth $978,000 after purchasing an additional 116,512 shares in the last quarter. North Star Investment Management Corp. boosted its position in Sharps Compliance by 10.0% during the third quarter. North Star Investment Management Corp. now owns 260,425 shares of the industrial products company’s stock worth $898,000 after purchasing an additional 23,775 shares in the last quarter. Wells Fargo & Company MN boosted its position in Sharps Compliance by 59.6% during the first quarter. Wells Fargo & Company MN now owns 227,500 shares of the industrial products company’s stock worth $1,033,000 after purchasing an additional 85,000 shares in the last quarter. Finally, Lapides Asset Management LLC boosted its position in Sharps Compliance by 24.8% during the third quarter. Lapides Asset Management LLC now owns 163,200 shares of the industrial products company’s stock worth $563,000 after purchasing an additional 32,400 shares in the last quarter. Institutional investors own 23.00% of the company’s stock.
Sharps Compliance Company Profile
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
See Also: Fiduciary
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.